Psychological welfare of patients with breast cancer
Despite millions of pounds spent on breast cancer research, a major breakthrough in terms of curing the disease still eludes us. Last year over 24500 women in the UK were newly diagnosed as having breast cancer and 15 000 women died from it. Thus it remains the biggest killer of western women in their middle years. Although these facts paint a somewhat gloomy picture, there have been some dramatic changes recently in the management ofthe disease. These are likely to improve considerably the quality of life, without necessarily adding to the length of life, for those women unfortunate enough to require breast cancer treatment.
One change, highlighted in the paper by Morris et al. ( this issue, p 12), concerns the clear shift towards more conservative surgical proceduresa trend likely to continue at a rapid pace as more encouraging results emerge from clinical trials throughout the world. Some women who still have to undergo mastectomy for technical reasons are however benefiting from better cosmesis, both in breast reconstruction techniques and the materials used for these and external prostheses. Another improvement in management has occurred with the advent of effective, non-toxic adjuvant therapy such as Tamoxifen. Trials are also in progress to establish whether or not Tamoxifen alone can be used with confidence to treat elderly breast cancer patients, thus saving them from the perils of surgery. The role of cytotoxic chemotherapy in breast cancer remains a controversial issue but the perceived need for aggressive treatment with high doses of distressingly toxic agents is receding, in this country at least. The past decade has also seen refinements in the techniques of radiation therapy which are undoubtedly quicker and safer than previously.
A further major area ofbeneficial change in breast cancer management concerns the psychological wellbeing of patients. There has been an increasing awareness by health professionals ofthe psychosocial havoc provoked by the disease and its treatment. Several enlightened hospitals now provide a liaison psychiatry service such as the one described by Ramirez (this issue, p 15). Others have spialist nurses in their breast clinics to provide counselling and prosthesis fitting. We have important data emerging from studies suggesting that the way in which the surgeon conducts the 'bad news' consultation, i.e. informing the patient of the diagnosis and treatment options, can have a major impact on short and longterm psychological outcome. In particular, the way in which different surgeons discuss the choice of treatment appears to be an interesting variable. Two small studies have suggested that women who are permitted some choice oftreatment wherever possible, display a more positive psychological adjustment than those offered no choicel2. We await the results from a large prospective study of 300 patients to see ifthese apparent benefits are maintained even when women develop a recurrence of their disease3.
It is important to emphasize that merely preserving a woman's breast does not guarantee protection from psychological and sexual dysfunction4. Patients who avoid the disfigurement of mutilating surgery nevertheless still have to contend with the fact that they have had cancer. Our own research has shown that women treated by conservative surgery still have many unmet psychological needs5. Fortunately there are ways to ameliorate some of the distress caused by a diagnosis of breast cancer and its treatment.
We offer below 10 guidelines based on current knowledge which given good will and resources, should substantially improve the quality of life for women with breast cancer.
(1) Before the 'bad news' interview establish whether or not the patient is happily married or has a close companion with her. Ifthe patient consents invite this partner to attend the interview so that you have a committed ally in your attempts to provide psychosocial support5.
(2) Identify the patient most at risk of developing serious psychological morbidity after the diagnosis and treatment of breast cancer. She is likely to be someone without a partner or network of family support6. A woman going through some other life crisis such as bereavement, divorce, moving house, coping with redundancy or children leaving home, is also at risk. The doctor should be alert to the likelihood of serious problems of adaptation in patients with a previous history of depressive illness or chronic anxiety7.
(3) Employ a professional, adequately trained counsellor in the clinic. Ideally, this should be a mature nurse who has attended a recognized training course for counselling cancer patients. It is not sufficient to choose the kindliest, most well-motivated nurse who has a lot of 'experience' with cancer patients and assume that they will have all the necessary professional skills8. Very few doctors, despite good will, have the time or talents to fulfil a counselling role adequately. It is a professional skill which should be respected.
(4) Establish contact with your department of psychological medicine and try to identify one specific psychiatrist prepared to deal with any of the serious problems found by the professional counsellor9. There is an unfortunate tendency to assume that because anxiety and depression are 'normal' consequences of having cancer then such disorders do not merit treatment. This is as nonsensical as arguing that as pain is a natural consequence of cancer appropriate analgesia should not be given. Patients can benefit enormously not only from psychotherapy but also from anxiolytic and antidepressant therapy where appropriatel0, and only pressure from interested clinicians will change this misconception.
(5) Many women are made unnecessarily anxious and miserable by prolonged outpatient waiting times in unpleasant hospital environments. This is a particular problem for patients awaiting radiotherapy treatment. Proper appointment systems must be made and adhered to and the waiting areas could be brightened up so as not to compound the feelings ofgloom and despondency. suffer mastectomy due to technical reasons such as the size or position of the tumour relative to the size ofthe breast. Adequate prostheses fitted by a sensitive and competent fitter, preferably female, must be a priority. Many women describe their feelings of disgust and humiliation provoked by the deficiencies and inadequacies of the service currently provided in many of our hospitals11. Too many women leave hospital with a poor temporary prosthesis and little idea as to when and how an aesthetically more acceptable prosthesis will be fitted. This is a fundamental right for any woman to help compensate for the loss of her breast and should not be hampered by artificial financial constraints or bureaucracy. Provision of a prosthesis should be treated with precisely the same respect as any other aspect ofthe patient's care.
(7) Women treated by local excision and postoperative radiotherapy are not automatically guaranteed a clean psychological bill of health just because they have avoided breast loss. Their psychological needs must be acknowledged and addressed. In particular they need constant reassurance that preserving the breast has not necessarily compromised survival. The almost obsessional re-examination and repeat mammographies do little to palliate this anxiety. If clinicians embark upon breast conservation as primary therapy, they should have the courage of their convictions, recognizing that in the few cases where local control fails, delayed mastectomy can salvage the situation without necessarily having put the patient's life at risk. (8) However trivial the follow-up visits might be to clinicians it is an extremely anxious time for the patient. Many experience considerable distress, contemplating whether or not the next visit will demonstrate a feared recurrence which will be an early signal of impending demise. The follow-up for patients having been treated for early carcinoma ofthe breast is often relegated to the most junior member ofthe staff, and as a result, there is little continuity of care. To improve communications and reassure patients adequately women should always be seen by the same responsible treating clinician5.
(9) If a patient's breast cancer does recur and she requires treatment for advanced disease, it should be recognized that this treatment is only palliative; such patients are all condemned to die within one or two years. There is a dearth of evidence currently available suggesting that any particular treatment strategy at this stage significantly prolongs survival. It is therefore essential to remember that the criterion of benefit must be quality of survival rather than length of survival. It is time that some form of assessment of quality oflife becomes a mandatory requirement incorporated into treatment and research protocols12. (10) Finally, good professional terminal care and support must be available to ease the stress of dying felt by both the patient and her immediate family when all the benefits of conventional active treatment have been exhausted. Although active therapy should cease at this stage, many patients display an admirable altruism and may be happy to volunteer for Phase I and Phase II trials of new therapy but this should only be offered following informed consent.
Having breast cancer is an awesome burden for womenwe have a duty and responsibility to lighten their load considerably, by ensuring that our treatments are based on sound research findings from both clinical and psychological trials. 
